Market Overview:
The global N-ethylpiperazine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for N-ethylpiperazine as a chemical intermediate and pharmaceutical intermediate. Additionally, the growing demand for N-ethylpiperazine from emerging economies is also contributing to the growth of the market. However, volatility in prices of raw materials may restrain the growth of this market during the forecast period. On basis on type, N-Ethylpiperazine 99% held major share in global n-ethylpiperazine market followed by n-ethyplperazine 99.5%. On basis on application, chemical intermediates accounted for majority share in global n - ethyl piperazines followed by pharmaceutical intermediates .
Product Definition:
N-ethylpiperazine (NEP) is a psychoactive drug of the piperazine class. It is used recreationally as a euphoriant and stimulant, and in the treatment of ADHD. NEP has also been shown to act as an agonist at the 5-HT2B receptor, which may account for its hallucinogenic effects.
N-Ethylpiperazine 99.5%:
N-ethylpiperazine, also known as N-Ethyl Piperazine or NIPA is a colorless and flammable organic compound. It has a strong odor similar to that of ethyl alcohol. It is soluble in ethanol, acetone and water but not in diethyl ether.
It was previously used as an intermediate for the synthesis of piperazines which are important chemical building blocks for many chemicals such as pesticides, herbicides.
N-Ethylpiperazine 99%:
N-ethylpiperazine is a colorless and flammable liquid with a mild odor.
Application Insights:
The global N-ethylpiperazine market has been segmented on the basis of application into chemical intermediate, pharmaceutical intermediate and others. The chemical intermediate segment dominated the overall industry in terms of revenue share at over 40% in 2017. This is attributed to increasing demand for piperazines as a chemical intermediate for production of other industrial chemicals and pharmaceuticals such as antacids, analgesics, anthelmintics (medicine used to treat parasitic infections), barbiturates, bromides (medicine used to treat bronchitis), codeine cough syrups/mixtures (a medicine that contains opium or morphine) diuretics (a drug that increases urine flow) and vitamins.
N-ethylpiperazine is widely utilized as a Pharmaceutical Intermediate due its high lipophilicity which allows it to cross biological membranes easily.
Regional Analysis:
Asia Pacific dominated the global market in terms of revenue with a share of over 60% in 2017. This is attributed to the presence of key manufacturers such as Shandong Tianzhan Pharmaceutical Co., Ltd., and Sun pharma limited, which have their manufacturing plant based in this region. The growing pharmaceutical industry coupled with rising demand for chemical intermediate products is expected to drive regional growth during the forecast period.
The European market was valued at USD X million in 2017 and is expected to witness steady growth over the forecast period owing to high demand from end-use industries such as agrochemicals, pharmaceuticals, cosmetics & personal care products among others. In addition, increasing R&D activities by various companies are anticipated to fuel product consumption across this region during the estimated time span (2018 - 2030).
Growth Factors:
- Increasing demand for N-ethylpiperazine in various end-use industries such as pharmaceuticals, agrochemicals, and others is expected to drive the growth of the market over the forecast period.
- Growing demand for N-ethylpiperazine from emerging countries is another key factor that is expected to fuel the growth of the market during the forecast period.
- Rising investments by key players in research and development activities to develop new applications of N-ethylpiperazine is anticipated to propel market growth over the next few years.
- Stringent environmental regulations regarding VOC emissions are projected to create opportunities for manufacturers of N-ethylpiperazine in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
N-Ethylpiperazine Market Research Report
By Type
N-Ethylpiperazine 99.5%, N-Ethylpiperazine 99%
By Application
Chemical Intermediate, Pharmaceutical Intermediate
By Companies
BASF, Guobang Pharma, Diamines and Chemicals Ltd., Shaoxing Xingxin New Materials, Changzhou Hengda Chemical, Koei Chemical Co., Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global N-Ethylpiperazine Market Report Segments:
The global N-Ethylpiperazine market is segmented on the basis of:
Types
N-Ethylpiperazine 99.5%, N-Ethylpiperazine 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemical Intermediate, Pharmaceutical Intermediate
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF
- Guobang Pharma
- Diamines and Chemicals Ltd.
- Shaoxing Xingxin New Materials
- Changzhou Hengda Chemical
- Koei Chemical Co., Ltd
Highlights of The N-Ethylpiperazine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- N-Ethylpiperazine 99.5%
- N-Ethylpiperazine 99%
- By Application:
- Chemical Intermediate
- Pharmaceutical Intermediate
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the N-Ethylpiperazine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
N-ethylpiperazine is a psychoactive drug that is used to treat anxiety and depression. It works by affecting the chemicals in the brain that can cause these conditions.
Some of the key players operating in the n-ethylpiperazine market are BASF, Guobang Pharma, Diamines and Chemicals Ltd., Shaoxing Xingxin New Materials, Changzhou Hengda Chemical, Koei Chemical Co., Ltd.
The n-ethylpiperazine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 N-Ethylpiperazine Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 N-Ethylpiperazine Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 N-Ethylpiperazine Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the N-Ethylpiperazine Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global N-Ethylpiperazine Market Size & Forecast, 2018-2028 4.5.1 N-Ethylpiperazine Market Size and Y-o-Y Growth 4.5.2 N-Ethylpiperazine Market Absolute $ Opportunity
Chapter 5 Global N-Ethylpiperazine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 N-Ethylpiperazine Market Size Forecast by Type
5.2.1 N-Ethylpiperazine 99.5%
5.2.2 N-Ethylpiperazine 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global N-Ethylpiperazine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 N-Ethylpiperazine Market Size Forecast by Applications
6.2.1 Chemical Intermediate
6.2.2 Pharmaceutical Intermediate
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global N-Ethylpiperazine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 N-Ethylpiperazine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America N-Ethylpiperazine Analysis and Forecast
9.1 Introduction
9.2 North America N-Ethylpiperazine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America N-Ethylpiperazine Market Size Forecast by Type
9.6.1 N-Ethylpiperazine 99.5%
9.6.2 N-Ethylpiperazine 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America N-Ethylpiperazine Market Size Forecast by Applications
9.10.1 Chemical Intermediate
9.10.2 Pharmaceutical Intermediate
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe N-Ethylpiperazine Analysis and Forecast
10.1 Introduction
10.2 Europe N-Ethylpiperazine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe N-Ethylpiperazine Market Size Forecast by Type
10.6.1 N-Ethylpiperazine 99.5%
10.6.2 N-Ethylpiperazine 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe N-Ethylpiperazine Market Size Forecast by Applications
10.10.1 Chemical Intermediate
10.10.2 Pharmaceutical Intermediate
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific N-Ethylpiperazine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific N-Ethylpiperazine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific N-Ethylpiperazine Market Size Forecast by Type
11.6.1 N-Ethylpiperazine 99.5%
11.6.2 N-Ethylpiperazine 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific N-Ethylpiperazine Market Size Forecast by Applications
11.10.1 Chemical Intermediate
11.10.2 Pharmaceutical Intermediate
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America N-Ethylpiperazine Analysis and Forecast
12.1 Introduction
12.2 Latin America N-Ethylpiperazine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America N-Ethylpiperazine Market Size Forecast by Type
12.6.1 N-Ethylpiperazine 99.5%
12.6.2 N-Ethylpiperazine 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America N-Ethylpiperazine Market Size Forecast by Applications
12.10.1 Chemical Intermediate
12.10.2 Pharmaceutical Intermediate
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) N-Ethylpiperazine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) N-Ethylpiperazine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) N-Ethylpiperazine Market Size Forecast by Type
13.6.1 N-Ethylpiperazine 99.5%
13.6.2 N-Ethylpiperazine 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) N-Ethylpiperazine Market Size Forecast by Applications
13.10.1 Chemical Intermediate
13.10.2 Pharmaceutical Intermediate
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 N-Ethylpiperazine Market: Competitive Dashboard
14.2 Global N-Ethylpiperazine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BASF
14.3.2 Guobang Pharma
14.3.3 Diamines and Chemicals Ltd.
14.3.4 Shaoxing Xingxin New Materials
14.3.5 Changzhou Hengda Chemical
14.3.6 Koei Chemical Co., Ltd